2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Canada Leader Award
2011 - Fellow of the Royal Society of Canada Academy of Science
His primary areas of investigation include Parkinson's disease, Central nervous system disease, Neuroscience, Disease and Internal medicine. The various areas that he examines in his Parkinson's disease study include Dopaminergic, Physical therapy and Parkinsonism. Unified Parkinson's disease rating scale is closely connected to Movement disorders in his research, which is encompassed under the umbrella topic of Physical therapy.
The Central nervous system disease study which covers Deep brain stimulation that intersects with Stimulation. Anthony E. Lang has researched Disease in several fields, including Psychiatry, Neurology, Physical medicine and rehabilitation and Intensive care medicine. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Oncology and Cardiology.
Anthony E. Lang spends much of his time researching Parkinson's disease, Neuroscience, Disease, Internal medicine and Parkinsonism. His Parkinson's disease study incorporates themes from Physical therapy, Central nervous system disease and Physical medicine and rehabilitation. Within one scientific family, Anthony E. Lang focuses on topics pertaining to Psychiatry under Disease, and may sometimes address concerns connected to Movement disorders.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Oncology and Cardiology. His Parkinsonism research is included under the broader classification of Pathology. His biological study spans a wide range of topics, including Anesthesia and Dyskinesia.
His primary areas of study are Parkinson's disease, Disease, Neuroscience, Internal medicine and Movement disorders. The study incorporates disciplines such as Neurology, Physical medicine and rehabilitation, Parkinsonism and Clinical trial in addition to Parkinson's disease. His Physical medicine and rehabilitation study frequently draws connections to other fields, such as Deep brain stimulation.
His research investigates the link between Disease and topics such as Cognition that cross with problems in Clinical psychology. Anthony E. Lang works mostly in the field of Neuroscience, limiting it down to topics relating to Progressive supranuclear palsy and, in certain cases, Lewy body. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Oncology and Cardiology.
Anthony E. Lang mainly investigates Parkinson's disease, Disease, Neuroscience, Pathology and MEDLINE. His study in Parkinson's disease is interdisciplinary in nature, drawing from both Psychiatry, Neurology, Parkinsonism and Dopamine. His study with Disease involves better knowledge in Internal medicine.
His Neuroscience study combines topics from a wide range of disciplines, such as Levodopa, Movement disorders and Deep brain stimulation. His studies deal with areas such as Transcranial magnetic stimulation, Neuroplasticity and Physical therapy as well as Deep brain stimulation. His research integrates issues of Essential tremor, Randomized controlled trial, Bioinformatics and Intensive care medicine in his study of MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)
Parkinson's disease. First of two parts.
A E Lang;A M Lozano.
The New England Journal of Medicine (1998)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
Levodopa and the progression of Parkinson's disease.
Stanley Fahn;David Oakes;Ira Shoulson;Karl Kieburtz.
The New England Journal of Medicine (2004)
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.
Obeso Ja;Olanow Cw;Rodriguez-Oroz Mc.
The New England Journal of Medicine (2001)
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
Rascol O;Brooks Dj;Korczyn Ad;De Deyn Pp.
The New England Journal of Medicine (2000)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz.
The New England Journal of Medicine (2009)
Phenomenology and classification of dystonia: a consensus update.
Alberto Albanese;Kailash Bhatia;Susan B. Bressman;Mahlon R. DeLong.
Movement Disorders (2013)
Parkinson's disease. Second of two parts.
A E Lang;A M Lozano.
The New England Journal of Medicine (1998)
Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients
Daniel Weintraub;Juergen Koester;Marc N. Potenza;Andrew D. Siderowf.
JAMA Neurology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Health Network
University Health Network
Joseph Fourier University
University of Toronto
Krembil Research Institute
University of Lübeck
University of Toronto
University of Toronto
University of Toronto
University of California, San Diego
IBM (United States)
University College London
Clarkson University
Prairie View A&M University
TU Dortmund University
University of Oxford
Erasmus MC
Rady Children's Hospital-San Diego
Texas A&M University
Spanish National Research Council
Roche (Switzerland)
University of Florida
University of Würzburg
University of Wisconsin–Madison
University College London
Lawrence Berkeley National Laboratory